Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke

FDA inspection history in Pudong New Area, China, 2026

1
Form 483

Every document, by year

  • Form 483

2026: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2026One Form 483, at Pudong New Area, China.

Cited most

Across all Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke observations on file

The complete Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2026-03-20483 Form 483$99

Investigators on these documents

Richard W. Berning (1)

FEI number 3020982471 · most recent document Mar 20, 2026

About Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke

How many FDA Form 483s has Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke received?

FDA Intel has 1 Form 483 on file for Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke; the most recent is dated Mar 20, 2026.

When was Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke last inspected by FDA?

The most recent FDA inspection document on file for Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke is a Form 483 dated Mar 20, 2026, for the site in Pudong New Area, China.

What did FDA cite at Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke?

The regulations cited most in the observations on file for Abbisko Therapeutics Co., Ltd. 12B Floor, Building 1, Lane 515, Huanke are 21 CFR 312.50 (General responsibilities of sponsors), 1 time.